FDA Approved: ONCASPAR — Supplemental Application (Servier Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a Supplemental Application for ONCASPAR (pegaspargase) from Servier Pharmaceuticals LLC, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Oncaspar (pegaspargase)

Snippet

SUPPL AP for ONCASPAR (PEGASPARGASE)